Publikationen von W. Zieglgänsberger

Hapfelmeier, G.; Tredt, C.; Haseneder, R.; Zieglgänsberger, W.; Eisensamer, B.; Rupprecht, R.; Rammes, G.: Co-expression of the 5-HT3B serotonin receptor subunit alters the biophysics of the 5-HT3 receptor. Biophysical Journal 84 (3), S. 1720 - 1733 (2003)

Rammes, G.; Palmer, M.; Eder, M.; Dodt, H. U.; Zieglgänsberger, W.; Collingridge, G. L.: Activation of mGlu receptors induces LTD without affecting postsynaptic sensitivity of CA1 neurons in rat hippocampal slices. Journal of Physiology-London 546 (2), S. 455 - 460 (2003)

Azad, S. C.; Zieglgänsberger, W.: Was wissen wir über die Chronifizierung von Schmerz? Der Schmerz 17, S. 441 - 444 (2003)

Berthele, A.; Platzer, S.; Dworzak, D.; Schadrack, J.; Mahal, B.; Buttner, A.; Assmus, H. P.; Wurster, K.; Zieglgänsberger, W.; Conrad, B. et al.; Tölle, T. R.: [3H]-nociceptin ligand-binding and nociceptin opioid receptor mRNA expression in the human brain. Neuroscience 121 (3), S. 629 - 640 (2003)

Eder, M.; Becker, K.; Rammes, G.; Schierloh, A.; Azad, S. C.; Zieglgänsberger, W.; Dodt, H.-U.: Distribution and properties of functional postsynaptic kainate receptors on neocortical layer V pyramidal neurons. The Journal of Neuroscience 23 (16), S. 6660 - 6670 (2003)

Eisensamer, B.; Rammes, G.; Gimpl, G.; Shapa, M.; Ferrari, U.; Hapfelmeier, G.; Bondy, B.; Parsons, C.; Gilling, K.; Zieglgänsberger, W. et al.; Holsboer, F.; Rupprecht, R.: Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor. Molecular Psychiatry 8 (12), S. 994 - 1007 (2003)

Littleton, J.; Zieglgänsberger, W.: Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence. The American Journal on Addictions 12 (Suppl 1), S. S3 - S11 (2003)

Haseneder, R.; Rammes, G.; Zieglgänsberger, W.; Kochs, E.; Hapfelmeier, G.: GABA_A receptor activitation and open-channel block by volatile anaesthetics: a new principle of receptor modulation? European Journal of Pharmacology 451, S. 43 - 50 (2002)

Azad, S. C.; Marsicano, G.; Eberlein, I.; Putzke, J.; Zieglgänsberger, W.; Spanagel, R.; Lutz, B.: Differential role of the nitric oxide pathway on Δ⁹-THC-induced central nervous system effects in the mouse. European Journal of Neuroscience 13, S. 561 - 568 (2001)

Eder, M.; Rammes, G.; Zieglgänsberger, W.; Dodt, H.-U.: GABA_A and GABA_B receptors on neocortical neurons are differentially distributed. European Journal of Neuroscience 13, S. 1065 - 1069 (2001)

Frick, A.; Zieglgänsberger, W.; Dodt, H.-U.: Glutamate receptors form hot spots on apical dendrites of neocortical pyramidal neurons. Journal of Neurophysiology 86, S. 1412 - 1421 (2001)

Hapfelmeier, G.; Haseneder, R.; Eder, M.; Adelsberger, H.; Kochs, E.; Rammes, G.; Zieglgänsberger, W.: Isoflurane slows inactivation kinetics of rat recombinant α₁β₂γ_2L GABA_A receptors: enhancement of GABAergic transmission despite an open-channel block. Neuroscience Letters 307, S. 97 - 100 (2001)

Hapfelmeier, G.; Haseneder, R.; Kochs, E.; Beyerle, M.; Zieglgänsberger, W.: Coadministered nitrous oxide enhances the effect of isoflurane on GABAergic transmission by an increase in open-channel block. Journal of Pharmacology and Experimental Therapeutics 298, S. 201 - 208 (2001)

Rammes, G.; Eder, M.; Dodt, H.-U.; Kochs, E.; Zieglgänsberger, W.: Long-term depression in the basolateral amygdala of the mouse involves the activation of interneurons. Neuroscience 107, S. 85 - 97 (2001)

Rammes, G.; Mahal, B.; Putzke, J.; Parsons, C.; Spielmanns, P.; Pestel, E.; Spanagel, R.; Zieglgänsberger, W.; Schadrack, J.: The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801. Neuropharmacology 40, S. 749 - 760 (2001)

Rammes, G.; Rupprecht, R.; Ferrari, U.; Zieglgänsberger, W.; Parsons, C. G.: The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT₃ receptor currents in cultured HEK-293 and N 1 E-115 cell systems in a non-competitive manner. Neuroscience Letters 306, S. 81 - 84 (2001)

Simon, W.; Hapfelmeier, G.; Kochs, E.; Zieglgänsberger, W.; Rammes, G.: Isoflurane blocks synaptic plasticity in the mouse hippocampus. Anesthesiology 94, S. 1058 - 1065 (2001)

Steckler, T.; Rammes, G.; Sauvage, M.; van Gaalen, M. M.; Weis, C.; Zieglgänsberger, W.; Holsboer, F.: Effects of the monoamine oxidase A inhibitor moclobemide on hippocampal plasticity in GR-impaired transgenic mice. Journal of Psychiatric Research 35, S. 29 - 42 (2001)

Winkelmann, J.; Schadrack, J.; Wetter, T. C.; Zieglgänsberger, W.; Trenkwalder, C.: Opioid and dopamine antagonist drug challenges in untreated restless legs syndrome patients. Sleep Medicine 2, S. 57 - 61 (2001)

Engelhard, K.; Werner, C.; Lu, H.; Möllenberg, O.; Zieglgänsberger, W.; Kochs, E.: Der neuroprotektive Einfluss des Glutamat-Antagonisten Acamprosat nach experimenteller Ischämie. Ein Vergleich mit dem Lipidperoxidase-Inhibitor U-101033 E. Anaesthesist 49, S. 816 - 821 (2000)